PARATHYROID-HORMONE IN BLOOD-PRESSURE AND VOLUME HOMEOSTASIS IN HEALTHY-SUBJECTS, HYPERPARATHYROIDISM, LIVER-CIRRHOSIS AND GLOMERULONEPHRITIS - A POSSIBLE INTERACTION WITH ANGIOTENSIN-II AND ATRIAL-NATRIURETIC-PEPTIDE
B. Jespersen et al., PARATHYROID-HORMONE IN BLOOD-PRESSURE AND VOLUME HOMEOSTASIS IN HEALTHY-SUBJECTS, HYPERPARATHYROIDISM, LIVER-CIRRHOSIS AND GLOMERULONEPHRITIS - A POSSIBLE INTERACTION WITH ANGIOTENSIN-II AND ATRIAL-NATRIURETIC-PEPTIDE, Scandinavian journal of clinical & laboratory investigation, 54(7), 1994, pp. 531-541
In order to elucidate a participation of intact parathyroid hormone (P
TH(1-84)) in blood pressure (BP) and body fluid homeostasis, we studie
d fluctuations of PTH(1-84) during manipulations of BP in hyperparathy
roid and healthy subjects, and during manipulations of blood volume in
patients with glomerulonephritis or liver cirrhosis and in controls.
Angiotensin II induced BP elevation was associated with increased valu
es of PTH(1-84) both in healthy subjects (12-25 ngl(-1), medians, p <
0.01), in patients with primary hyperparathyroidism (94-125 ngl(-1), p
< 0.01), in patients with low calcium due to end stage renal disease
before requirement of dialysis (95-151 ngl(-1), p < 0.02), and in pati
ents with tertiary hyperparathyroidism (221-264 ngl(-1), p < 0.05), bu
t not in dialysis patients without hypercalcaemia (126-174 ngl(-1), NS
). The changes could not be attributed to reduction of serum calcium,
but probably to the increase of plasma angiotensin II, which was posit
ively correlated to the increase of serum PTH(1-84) in the healthy sub
jects (rho = 0.619, n = 15, p < 0.05) and in the patients with primary
hyperparathyroidism (rho = 0.549, n = 18, p < 0.05). Noradrenaline in
duced BP elevation did not have a similar effect on PTH(1-84), and cha
nges of PTH(1-84) were not related to changes of BP. Volume depletion
after furosemide injection, also accompanied by increased levels of an
giotensin II, resulted in elevation of PTH(1-84) in controls, cirrhoti
cs, patients with glomerulonephritis without the nephrotic syndrome, b
ut in nephrotic patients. Volume depletion induced by bolus injection
of atrial natriuretic peptide (ANP) was associated with decreased PTH(
1-84) in healthy subjects (20-18 ngl(-1) p < 0.02), but not in patient
s with nephrotic syndrome and liver cirrhosis. Volume expansion induce
d by albumin infusion caused increased plasma levels of ANP, but PTH(1
-84) was unaltered. Thus, angiotensin II may be able to stimulate, and
ANP to inhibit release of PTH(1-84), and PTH(1-84) may be involved in
the regulation of BP and body fluid homeostasis. BP changes or change
s in blood volume per se do not seem to influence PTH(1-84) levels.